Target intelligence / Profile preview

Non-UCP2 mRNAs with seed-region complementarity

Molecular classification
Messenger RNA (mRNA), Competing endogenous RNA (ceRNA)
01

Overview

The term Non-UCP2 mRNAs with seed-region complementarity refers to a heterogeneous population of messenger RNA (mRNA) transcripts that possess sequence motifs complementary to the seed regions (nucleotides 2-8) of microRNAs (miRNAs) that typically regulate Uncoupling Protein 2 (UCP2). These transcripts are not a single therapeutic target but rather a collective group of potential off-targets or competing endogenous RNAs (ceRNAs) that can sequester miRNAs such as miR-133, miR-15a, or miR-214. By binding these shared miRNAs, these mRNAs can indirectly modulate the expression of UCP2 and other genes within the same regulatory network, a phenomenon known as the ceRNA effect. In the development of RNA-based therapeutics, such as miRNA mimics or antagomirs, this group of molecules represents a significant challenge for drug specificity and safety. If a drug is designed to alter UCP2 levels by targeting its regulatory miRNAs, these complementary non-target mRNAs may be inadvertently silenced or upregulated, potentially leading to unintended biological consequences in metabolic or oncological pathways. Consequently, they are primarily analyzed during preclinical safety assessments to predict and mitigate systemic off-target effects (Bartel, 2009; Salmena et al., 2011; Poy et al., 2004).

Other names
Off-target transcriptsCompeting endogenous RNAs (ceRNAs) for UCP2-regulating miRNAsmiRNA decoy transcriptsSeed-matched non-target mRNAs
02

Mechanism of action

Competitive binding to the seed region of microRNAs (miRNA sponging), leading to the titration of miRNA activity away from the primary target (UCP2).

03

Biological functions

Post-transcriptional regulationmiRNA sequestrationGene silencing competitionRNA interference (RNAi) crosstalk
04

Disease associations

CancerMetabolic disordersType 2 diabetesObesity
05

Safety considerations

Off-target gene silencingUnintended metabolic shiftsSaturation of the RNA-induced silencing complex (RISC)Systemic toxicity due to multi-gene dysregulation
06

Interacting drugs

miRNA mimics (e.g., miR-133 mimics)

2 more in the full profile.

07

Biomarkers

Transcript abundance of off-target mRNAsmiRNA-RISC loading levelsGlobal protein expression profiles (proteomics)

Beyond the preview

Go deeper on Non-UCP2 mRNAs with seed-region complementarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-UCP2 mRNAs with seed-region complementarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call